Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:12:45.860Z.
Calculation as of: 2026-10-06T17:12:45.860Z.
Quote observation: 2026-10-06T17:07:49.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b6268879a98e6c39cef7c3f9e2e80a63ea5355fd191f52e510f01db01fc6dd59
EARNINGS YIELD
N/A
Greenwich LifeSciences, Inc.
Market Cap
$242.80M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.50M
Earnings Yield
N/A
TTM Avg
2.23%
3Y Avg
2.23%
5Y Avg
2.23%
Market Cap
$241.04M
Earnings Yield
N/A
TTM Avg
37.01%
3Y Avg
37.01%
5Y Avg
37.01%
Market Cap
$241.78M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.72M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | $242.80M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.50M | N/A | 2.23% | 2.23% | 2.23% |
| Q32 Bio Inc. (QTTB)vs › | $242.28M | 34.28% | 26.39% | 26.39% | 30.90% |
| Galectin Therapeutics Inc. (GALT)vs › | $241.04M | N/A | 37.01% | 37.01% | 37.01% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $241.78M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $239.72M | N/A | N/A | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $246.31M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $237.69M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $237.23M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $236.81M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute